Full Press Release Details
SALT LAKE CITY, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurological diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the following investor conferences in October.
2024 Maxim Healthcare Virtual Summit
Date: October 15-17, 2024
Presentation: October 15, 2024, at 2:30 p.m. E.T.
Format: Fireside Presentation and 1x1 meetings
Attendance: Sign up to become an M-Vest member
The ThinkEquity Conference 2024
Dates: October 30, 2024
Location: New York, New York, Mandarin Oriental Hotel
Presentation: October 30, 2024, at 3:30 p.m. E.T.
Format: Presentation and 1x1 meetings
Webcast Link: https://wsw.com/webcast/tep25/clnn/1673136